Diabetes & Metabolism

Article	Citations
Metformin and COVID-19: From cellular mechanisms to reduced mortality	140
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis	104
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment	100
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials	86
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients	85
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes	74
A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management	66
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes	65
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms	63
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19	58
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study	56
Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study	55
Elevated triglyceride–glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study	48
Meat and fish intake and type 2 diabetes: Dose–response meta-analysis of prospective cohort studies	47
Smoking and diabetes interplay: A comprehensive review and joint statement	47
Triglyceride–glucose index associates with incident heart failure: A cohort study	45
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19	40
Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study	35
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?	34
Fulminant type 1 diabetes after COVID-19 vaccination	33
Diabetes mellitus in the era of climate change	33
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations	31
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies	31
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction	29
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes	29

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19	28
The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies	26
Targeting ageing and preventing organ degeneration with metformin	26
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease	26
Diabetic ketoacidosis and mortality in COVID-19 infection	25
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement	25
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview	24
Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Dia	24
Eye disorders other than diabetic retinopathy in patients with diabetes	23
Practical implementation of automated closed-loop insulin delivery: A French position statement	23
Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study	23
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes	23
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors	22
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study	21
Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus	21
Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?	21
Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study	20
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement	20
Lower trabecular bone score in type 2 diabetes mellitus: A role for fat mass and insulin resistance beyond hyperglycaemia	20
SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?	19
The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients	19
Serum uric acid in early pregnancy and risk of gestational diabetes mellitus: A cohort study of 85,609 pregnant women	19
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes	19
The diuretic effects of SGLT2 inhibitors: A comprehensive review of their specificities and their role in renal protection	19
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes	19
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?	19
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists	18
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial	18
Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study	18
Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: A multi-institutional cohort study in Taiwan	17
Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic	16
Determinants of aspirin resistance in patients with type 2 diabetes	16
Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study	16
Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells	16
Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study	16
Associations of serum magnesium levels and calcium–magnesium ratios with mortality in patients with coronary artery disease	16
A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass	15
Association between sleep duration in early pregnancy and risk of gestational diabetes mellitus: a prospective cohort study	15
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study	15
Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection	15
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectI	15
Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study	15
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis	15
Concise review of lipidomics in nonalcoholic fatty liver disease	14
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort	14
Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function	14
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	14
Steatotic liver disease, MASLD and risk of chronic kidney disease	14
Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma	14
Bidirectional relationship between diabetes and pulmonary function: a systematic review and meta-analysis	13

Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers	13
Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin	13
Impact of gender on relative rates of cardiovascular events in patients with diabetes	13
Type 1 diabetes mellitus and risks of major psychiatric disorders: A nationwide population-based cohort study	12
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?	12
Dietary sodium and potassium and risk of diabetes: A prospective study using data from the China Health and Nutrition Survey	12
Dose–response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease	12
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes	12
Glycaemic variabilities: Key questions in pursuit of clarity	11
Distinct uric acid trajectories are associated with incident diabetes in an overweight Chinese population	11
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study	11
Prognosis associated with initial care of increased fasting glucose in early pregnancy: A retrospective study	11
SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus	11
Metabolic characteristics and adverse pregnancy outcomes for women with hyperglycaemia in pregnancy as a function of insulin resistance	11
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-	10
Efficacy of semaglutide versus liraglutide in clinical practice	10
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme	10
GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes	10
Gender and age differences in the association between sleep characteristics and fasting glucose levels in Chinese adults	10
Metformin treatment is associated with an increase in bone mineral density in type 2 diabetes mellitus patients in China: A retrospective single center study	10
Sleep duration and mortality in patients with diabetes: Results from the 2007–2015 Korea national health and nutrition examination survey	10
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes	10
Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs), it's time to give more credits to patients’ voice in research: the example of assessing hypoglycemia burden	10
Effects of H1-Antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus	9
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors	9
Associations between serum total, free and bioavailable testosterone and non-alcoholic fatty liver disease in community-dwelling middle-aged and elderly women	9
Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure	9
Significant association between blood lead (Pb) level and haemoglobin A1c in non-diabetic population	9
Immune checkpoint inhibitors and diabetes: Mechanisms and predictors	9
A low-carbohydrate high-fat diet initiated promptly after diagnosis provides clinical remission in three patients with type 1 diabetes	8
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong	8
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial	8
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies	8
Is there a residual risk of large-for-gestational-age infant related to gestational diabetes mellitus when it is treated?	8
Associations of visit-to-visit fasting glucose with risk of mortality: A retrospective cohort study of 48,077 people with type 2 diabetes	8
Transitions in metabolic health status over time and risk of heart failure: A prospective study	8
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis	8
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes	8
Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings	7
Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: A nationwide cohort study of patients with type 2 diabetes	7
Healing of diabetic foot ulcers is independently associated with the use of angiotensin receptor blockers but not with those of diuretics and angiotensin conversion enzyme inhibitors	7
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes	7
Towards individualised and optimalised positioning of non-ventilated COVID-19 patients: Putting the affected parts of the lung(s) on top?	7
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes	7
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood	7
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes	7
Whole-exome sequencing identifies the first French MODY 6 family with a new mutation in the NEUROD1 gene	7
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes	7
PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD	7
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design	6
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study	6
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease	6
Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials	6
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus	6
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	6
Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins	6
A healthful plant-based diet is associated with lower type 2 diabetes risk via improved metabolic state and organ function: A prospective cohort study	6
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation	6
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial	6
Variability in clinical presentation of diabetes mellitus during anti-PD-1 immunotherapy	6
Do GLP-1RAs and SGLT-2is reduce cardiovascular events in women with type 2 diabetes? A systematic review and meta-analysis	6
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study	6
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes	6
Physical activity and diabetes mortality in people with type 2 diabetes: a prospective cohort study of 0.5 million US people	6
Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort	6
Influence of sexual orientation on diabetes management in US adults with diabetes	6
Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory	6
Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses	6
Remission of necrobiosis lipoidica diabeticorum with a JAK1/2 inhibitor: A case report	6
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes	5
Overweight and risk of type 2 diabetes: A prospective Chinese twin study	5
HbA1c variability and diabetes complications: assessment and implications	5
Could metformin modulate cardiovascular outcomes differently with DPP-4 inhibitors compared with SGLT2 inhibitors?	5
Diabetes is not associated with COVID-19-related mortality in older institutionalized people	5
Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients	5
Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke	5
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications	5
Anaemia and its risk factors and association with treatments in patients with diabetes: A cross-sectional study	5
Cardiac arrhythmias and electrophysiologic responses during spontaneous hyperglycaemia in adults with type 1 diabetes mellitus	5
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance.	5

Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus	5
Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker	5
Liraglutide-induced effects on energy intake and glycemic profile are independent of total and intact GDF-15 levels in subjects with obesity and diabetes	5
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study	5
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study	5
Lifestyle changes in patients with morbid obesity and type 2 diabetes mellitus during the COVID-19 pandemic	5
Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study	4
Pumps that predict and manage low blood glucose are superior to pumps with stand-alone CGM for reducing hypoglycaemia in type 1 diabetes patients in a real-world setting	4
Monitoring gestational diabetes mellitus patients with the telemedicine application MyDiabby decreases the rate of foetal macrosomia	4
Lung function as a predictor of incident type 2 diabetes in community-dwelling adults: A longitudinal finding over 12 years from the Korean Genome and Epidemiology Study	4
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients	4
Clinical relevance of coronary risk classification and reclassification with coronary artery calcium score in asymptomatic people living with diabetes. An observational study	4
Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY3	4
Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes	4
Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study	4
Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine	4
Early origins of metabolic and overall health in young adults: An outcome-wide analysis in a general cohort population	4
Self-reported haemoglobin A1c highly agrees with laboratory-measured haemoglobin A1c among adults living with type 1 diabetes: A BETTER registry study	4
Key indices of glycaemic variability for application in diabetes clinical practice	4
Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study	4
Metformin use is associated with a lower risk of rotator cuff disease in patients with Type 2 diabetes mellitus	4
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer	4
Glycemic status during pregnancy according to fasting and post-load glucose values: The association with adverse pregnancy outcomes. An observational study	3
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes	3
Statistical and clinical significances: Are they equivalent?	3
Maternal autoimmune disease associated with a higher risk of offspring with type 1 diabetes: A nationwide mother-child cohort study in Taiwan	3
Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study	3
Association between glycemic status and age-related macular degeneration: A nationwide population-based cohort study	3
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study	3
Incretin response in immune checkpoint inhibitor-induced diabetes: an observational study	3
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT	3
1-h post-load plasma glucose for detecting early stages of prediabetes	3
Indispensable but deceptive evidence-based medicine	3
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes	3
Effect of yoga on reducing glycaemic variability in individuals with type 2 diabetes: A randomised controlled trial	3
Fasting serum copeptin and asymptomatic peripheral artery disease: No association in patients with type 1 diabetes mellitus	3
Compared impact of diabetes on the risk of heart failure from acute myocardial infarction to chronic coronary artery disease	3
Use of SGLT2 inhibitors after bariatric/metabolic surgery: Risk/benefit balance	3
Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis	3
Effect of glucose regulation on renal parenchyma and sinus fat volume in patients with type 2 diabetes	3
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment	3
Excessive dietary sodium intake augments long-term risk of atrial fibrillation in older adults with hyperglycemia: A community-based prospective cohort study	3
Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: Lessons for precision medicine	3
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus	3
Increased mortality risk associated with statins in the CORONADO study	3
A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children wi	3
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction	3
High frequency of transaminase elevation following diabetic ketoacidosis	3